CSR

18 04, 2024

{simaerep} v0.5.0 now available

2024-04-18T14:41:28-04:00April 18, 2024|CSR, News, Work Products|

{simaerep} was originally developed to detect sites that are under-reporting Adverse Events (AE) in clinical trials using a nonparametric bootstrap algorithm. With the release of the most current version v0.5.0 {simaerep} can also be used to detect over-reporting. With this [...]

Read More
9 11, 2023

IMPALA Webinar: Recording Available

2023-11-10T10:49:46-05:00November 9, 2023|CSR, Work Products|

On November 9, 2023, IMPALA hosted a webinar on Embedding an Open Source Package into Analytics-Based Audits. During this presentation, Bjoern Koneswarakantha and Lisa Bennett of Roche discussed IMPALA’s Clinical Safety Reporting R package. This included testing, methodology,  cross-validation between [...]

Read More

The IMPALA Consortium provides the strategic focus for working across the Biopharmaceutical ecosystem to develop and gain industry-wide consensus for the adoption of improved QA using advanced analytics and best practices to be used across the industry; ultimately improving patient outcomes and quality care at greater efficiency and greater speed.

Copyright © | IMPALA Consortium.  All Rights Reserved.

Go to Top